Rotavirus Gastroenteritis Clinical Trial
Official title:
The Immunogenicity of Rotavirus Vaccine Under Different Age Schedules and the Impact of Withholding Breast Feeding Around the Time of Vaccination on the Immunogenicity of Rotarix Vaccine
Rotavirus is one of the most common causes of severe diarrhea, responsible for 40% of all
diarrhea related deaths in children worldwide. Two vaccines against Rotavirus, Rotarix® and
Rotateq® were licensed in many high and middle income countries in 2006, but lack of
efficacy data in low income countries had prevented WHO from making a universal
recommendation of their use until recently. This study will be conducted in Pakistan and
will look at two objectives:
1. To compare the immunogenicity of Rotarix® vaccine when administered at 6 and 10 weeks
of life and at 6, 10 and 14 weeks of life.
2. To compare the immunogenicity of Rotarix® vaccine in infants breast fed at the time of
vaccine administration with infants whose breast feeding is withheld for one hour
before and after vaccine administration.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01575197 -
Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana
|
Phase 4 | |
| Completed |
NCT01202201 -
A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Japan
|
N/A | |
| Completed |
NCT00953056 -
A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)
|
Phase 1 | |
| Completed |
NCT00737503 -
Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab
|
Phase 4 | |
| Completed |
NCT04185545 -
Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates
|
Phase 3 | |
| Completed |
NCT03474055 -
Study on Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compare Non-Inferiority With ROTASIIL (Lyophilized BRV-PV) in Healthy Infants in India
|
Phase 2/Phase 3 | |
| Completed |
NCT01236066 -
Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia
|
N/A | |
| Completed |
NCT00489567 -
Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden
|
N/A | |
| Completed |
NCT02584816 -
Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization
|
Phase 3 | |
| Completed |
NCT02062385 -
Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)
|
Phase 3 | |
| Completed |
NCT02133690 -
A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants
|
Phase 3 | |
| Completed |
NCT01177657 -
Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil
|
N/A | |
| Completed |
NCT00740935 -
Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.
|
Phase 4 | |
| Completed |
NCT01265355 -
Community Based Prevention of Rotavirus Gastroenteritis by a Functional Food Supplement
|
Phase 2/Phase 3 | |
| Completed |
NCT00169455 -
Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants
|
Phase 3 | |
| Completed |
NCT04819412 -
To Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavirus
|
Phase 3 | |
| Completed |
NCT02728869 -
Safety, Reactogenicity and Immunogenicity of Heat-stable Rotavirus Vaccine (HSRV) in Adults and Infants
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05958771 -
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
|
Phase 3 | |
| Recruiting |
NCT01061658 -
Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine
|
Phase 1/Phase 2 | |
| Completed |
NCT01508533 -
Epidemiology of Rotavirus Infection in North India Community
|
N/A |